SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology (WOK) is experiencing extreme volatility and intense trading volume after the company officially terminated its $200 million ATM equity offering agreement. The community is actively discussing the stock's massive intraday swings and parabolic moves, with many traders drawing comparisons to other high-momentum Chinese micro-cap runners and debating whether the surge represents a sustained squeeze or a classic pump-and-dump cycle.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is generating significant investor buzz as a strategic proxy for the upcoming Cerebras Systems IPO, with community members closely tracking the potential for massive infrastructure scale-up and increased GPU-as-a-service demand. Investors are actively debating the stock's valuation relative to its high-value contracts and recent hedge fund activity, leading to intense sentiment shifts as bulls eye double-digit price levels.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending after confirming the REGAL trial has reached 78 of the 80 required clinical events, bringing the data unblinding milestone within reach. Community sentiment is highly polarized, with longs anticipating a major valuation re-rate and potential buyout while bears remain skeptical about trial success and trial timelines.

Robinhood Ventures Fund I invest in companies located in the United States. The fund focuses on a broad range of sectors and industries. It provides financing for early stage transactions.

Robinhood Ventures Fund I - Common shares of beneficial interest

Robinhood Ventures Fund I (RVI) is seeing significant retail interest and volatility as investors speculate on its portfolio potential, particularly regarding exposure to high-profile companies like OpenAI and Databricks. Community sentiment is divided between optimism for long-term growth and frustration over initial price performance, with active debates centered on how its valuation compares to other private-market closed-end funds.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is facing intense volatility and shareholder skepticism as investors pivot away from drone sector sentiment, demanding tangible contract execution and revenue growth rather than management's past forward-looking statements. The community is sharply divided, with bulls pointing to the company's manufacturing scalability and defense potential, while bears and frustrated investors are heavily focused on the company's history of missed expectations and dilution risks.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is experiencing significant momentum and volatility as market participants re-rate the company's prospects following its recent restructuring and heavy focus on Silicon Carbide technology for AI data center infrastructure. The community is sharply divided, with bulls pointing to the company's vertical integration and SiC demand as a critical AI play, while bears caution that financial health remains a primary concern following recent share dilution and bankruptcy history.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing significant upward price momentum driven by investor enthusiasm surrounding its solid-state battery technology and its strategic alignment with major material partners like Corning, which the community believes validates the company's potential in the AI data center and energy storage sectors. While there is no official news release, traders are actively speculating on a potential short squeeze, citing high short interest and institutional accumulation as catalysts for a larger breakout.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is rallying as community sentiment shifts around reports that Nelson Peltzs Trian Fund Management is seeking financing to take the company private. Investors are actively discussing the potential for a massive short squeeze given the high short interest, while many view the current valuation as an attractive entry point for a long-term turnaround.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is seeing significant investor attention following promising preclinical data for its ovarian cancer treatment candidate, which demonstrated complete tumor elimination in animal models. The stock is currently experiencing high volatility, with the community actively discussing potential squeezes, insider ownership, and the implications of recent financing and reverse split activities.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is experiencing significant community buzz as holders and AI enthusiasts discuss the project's utility, infrastructure on the Base chain, and the potential for a massive reevaluation driven by ongoing development. The discourse is heavily focused on long-term holding strategies and the anticipation of institutional adoption, despite recent short-term price volatility that has triggered active debates among traders regarding market manipulation and potential entry points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

SLTC
Selectica Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest SLTC News

SLTCSelectica Inc.